Want to join the conversation?
$LLY 2Q15 PR: Expects 2015 revenue to be $19.7-20.0Bil vs. prior guidance of $19.5-20.0Bil, reflecting solid 1H15 underlying performance, including the launch trajectories of Jardiance, Trulicity & Cyramza. 2015 financial outlook is subject to final acquisition accounting adjustments for acquisitions of Novartis Animal Health and Erbitux rights.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?